1-2 of 2
Donna Capozzi, PharmD, BCOP
Close
Sort by
Journal Articles

Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL)

Mitchell E. Hughes, PharmD, Daniel J. Landsburg, MD, Daniel J Rubin, PharmD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Donald Edward Tsai, MD PhD, Kyle Robinson, MD, Saar I. Gill, MDPhD, Anthony R. Mato, MDMSCE, James Nathan Gerson, MD, Danielle Land, CRNP, Brenda Shelly, CRNP, Alicia McLeish, CRNP, Allison Rago, CRNP, Jennifer Gill, CRNP, Kristy Walsh, BS, Tanya Latorre, RN, Jessica K. Altman, MD, Colleen Timlin, PharmD, Donna Capozzi, PharmD, BCOP, Sunita Dwivedy Nasta, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1706.
https://doi.org/10.1182/blood-2018-99-111194
Published: 2018
Journal Articles

Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas

Mitchell E. Hughes, PharmD, BCPS, BCOP, Christopher Jensen, MD, Jakub Svoboda, MD, Lauren Elizabeth Strelec, BA, Matthew R. Youngman, BS, Stephen J. Schuster, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Donald Edward Tsai, MD PhD, David Michael Mintzer, MD, Jennifer Gill, NP, MSN, Colleen Dorsey, BSN, Kaitlin Kennard, RN, BSN, Elizabeth T Chatburn, BS, Joanna Rhodes, MD, Krista Isaac, DO, MS, Kristy Walsh, BS, Tanya Latorre, BSN, RN, Kaley Piersanti, BS, Evan Bannister, BS, Colleen Timlin, PharmD, BCOP, Donna Capozzi, PharmD, BCOP, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1575.
https://doi.org/10.1182/blood.V130.Suppl_1.1575.1575
Published: 2017